New evidence for stroke prevention - Clinical applications

被引:28
作者
Straus, SE
Majumdar, SR
McAlister, FA
机构
[1] Univ Toronto, Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada
[2] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 11期
关键词
D O I
10.1001/jama.288.11.1396
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stroke is a leading cause of morbidity and mortality in most developed nations. There is a significant body of evidence supporting strategies that target primary and secondary stroke prevention. This evidence cannot be broadly applied to all patients, and each patient's situation and values must be considered with regard to shared evidence-based decision making. Several models can be used to apply evidence to individual patients, including formal clinical decision analysis, decision aids, or simpler tools such as the likelihood of being helped vs harmed. Various programmatic models of providing patient care in stroke prevention may also be useful; these include specialized clinics or disease-management programs, anticoagulation management services, and self-testing and management of anticoagulation by patients.
引用
收藏
页码:1396 / 1398
页数:3
相关论文
共 15 条
[1]   Consensus guidelines for coordinated outpatient oral anticoagulation therapy management [J].
Ansell, JE ;
Buttaro, ML ;
Thomas, IV ;
Knowlton, CH ;
Becker, DM ;
Bussey, HI ;
Corey, R ;
Gums, JG ;
Hughes, R ;
Jacobson, A ;
Kirchain, W ;
Kuhn, K ;
Loken, S ;
McCain, J ;
Haley, JA ;
Oertel, LB ;
Thrasher, K ;
Triplett, DA ;
Whitcomb, H ;
Wittkowsky, AK ;
Zarus, SA .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (05) :604-615
[2]   Comparison of an anticoagulation clinic with usual medical care -: Anticoagulation control, patient outcomes, and health care costs [J].
Chiquette, E ;
Amato, MG ;
Bussey, HI .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (15) :1641-1647
[3]   Oral anticoagulation self-management and management by a specialist anticoagulation clinic:: a randomised cross-over comparison [J].
Cromheecke, ME ;
Levi, M ;
Colly, LP ;
de Mol, BJM ;
Prins, MH ;
Hutten, BA ;
Mak, R ;
Keyzers, KCJ ;
Büller, HR .
LANCET, 2000, 356 (9224) :97-102
[4]   STROKE RISK PROFILE - ADJUSTMENT FOR ANTIHYPERTENSIVE MEDICATION - THE FRAMINGHAM-STUDY [J].
DAGOSTINO, RB ;
WOLF, PA ;
BELANGER, AJ ;
KANNEL, WB .
STROKE, 1994, 25 (01) :40-43
[5]   A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation - A randomized controlled trial [J].
Man-Son-Hing, M ;
Laupacis, A ;
O'Connor, AM ;
Biggs, J ;
Drake, E ;
Yetisir, E ;
Hart, RG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08) :737-743
[6]   Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls [J].
Man-Son-Hing, M ;
Nichol, G ;
Lau, A ;
Laupacis, A .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (07) :677-685
[7]  
Matchar DB, 2000, J THROMB THROMBOLYS, V9, pS7
[8]   Users' guides to the medical literature - XX. Integrating research evidence with the care of the individual patient [J].
McAlister, FA ;
Straus, SE ;
Guyatt, GH ;
Haynes, RB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (21) :2829-2836
[9]   Randomised trials of secondary prevention programmes in coronary heart disease: systematic review [J].
McAlister, FA ;
Lawson, FME ;
Teo, KK ;
Armstrong, PW .
BRITISH MEDICAL JOURNAL, 2001, 323 (7319) :957-962
[10]   Medicolegal implications of the Consensus Conference [J].
McIntyre, K .
CHEST, 2001, 119 (01) :337S-343S